This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2flg

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2flg.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2flg.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2flg| PDB=2flg | SCENE= }}
{{STRUCTURE_2flg| PDB=2flg | SCENE= }}
-
'''Solution structure of an EGF-LIKE domain from the Plasmodium falciparum merozoite surface protein 1'''
+
===Solution structure of an EGF-LIKE domain from the Plasmodium falciparum merozoite surface protein 1===
-
==Overview==
+
<!--
-
The Plasmodium falciparum merozoite surface protein-1 19 kDa fragment (MSP-1(19)) comprises two closely packed EGF-like domains (EGF=epidermal growth factor), each stabilized by three disulfide bonds. The native conformation of this protein is important for eliciting P. falciparum growth inhibitory antibodies. Here we show that the N-terminal EGF domain alone can be chemically synthesized and efficiently refolded to a native-like state, as shown by its solution structure as determined by NMR spectroscopy. In order to study its immunogenicity, the domain was coupled through its N terminus to a phospholipid and incorporated into reconstituted influenza virus-like particles (virosomes). When used to immunize mice, the peptide-loaded virosomes elicited potent humoral immune responses that were shown by Western blots and immunofluorescence assays to cross-react with native MSP-1 on the surfaces of P. falciparum blood stage parasites. This opens the way for a medicinal chemistry-oriented approach to the study and optimization of the antigenicity of the protein as a potential malaria vaccine candidate, whilst exploiting the immunopotentiating properties of influenza virosomes as a delivery vehicle.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17068840}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17068840 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17068840}}
==About this Structure==
==About this Structure==
-
2FLG is a [[Single protein]] structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FLG OCA].
+
2FLG is a [[Single protein]] structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2FLG OCA].
==Reference==
==Reference==
Line 31: Line 35:
[[Category: Surface antigen]]
[[Category: Surface antigen]]
[[Category: Surface protein]]
[[Category: Surface protein]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:01:51 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 13:09:21 2008''

Revision as of 10:09, 29 July 2008

Image:2flg.png

Template:STRUCTURE 2flg

Solution structure of an EGF-LIKE domain from the Plasmodium falciparum merozoite surface protein 1

Template:ABSTRACT PUBMED 17068840

About this Structure

2FLG is a Single protein structure. Full experimental information is available from OCA.

Reference

Synthesis, solution structure and immune recognition of an epidermal growth factor-like domain from Plasmodium falciparum merozoite surface protein-1., James S, Moehle K, Renard A, Mueller MS, Vogel D, Zurbriggen R, Pluschke G, Robinson JA, Chembiochem. 2006 Dec;7(12):1943-50. PMID:17068840

Page seeded by OCA on Tue Jul 29 13:09:21 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2flg"
Personal tools